Literature DB >> 20427190

RNA interference with 2',4'-bridged nucleic acid analogues.

S M Abdur Rahman1, Hiroyuki Sato, Naoto Tsuda, Sunao Haitani, Keisuke Narukawa, Takeshi Imanishi, Satoshi Obika.   

Abstract

In this study, a number of 2',4'-BNA- and 2',4'-BNA(NC)-modified siRNAs were designed and synthesized. Their thermal stability, nuclease resistance and gene silencing properties against cultured mammalian cells were evaluated and compared with those of natural siRNAs. The 2',4'-BNA- and 2',4'-BNA(NC)-modified siRNAs (named siBNA and siBNA(NC), respectively) showed very high T(m) values, were remarkably stable in serum sample and showed promising RNAi properties equal to those exhibited by natural siRNAs. Thermally stable siBNAs composed of slightly modified sense and antisense strands were capable of suppressing gene expression equal to that of natural siRNA. A number of modifications on the sense strand by 2',4'-BNA or 2',4'-BNA(NC), either consecutively or separated by natural RNA nucleotides, is tolerable in RNAi machinery. Modifications at the Argonauate (Ago2) cleavage site of the sense strand (9-11th positions from the 5'-end of the sense strand) produced variable results depending on siRNA composition. Mostly, modification at the 10th position diminished siRNA activity. In moderately modified siRNAs, modification at the 11th position displayed usual RNAi activity, while modification at the 9th position showed variable results depending on siRNA composition. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427190     DOI: 10.1016/j.bmc.2010.03.076

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo.

Authors:  Shunsuke Wada; Satoshi Obika; Masa-Aki Shibata; Tsuyoshi Yamamoto; Moeka Nakatani; Tetsuji Yamaoka; Hidetaka Torigoe; Mariko Harada-Shiba
Journal:  Mol Ther Nucleic Acids       Date:  2012-09-18       Impact factor: 10.183

2.  In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.

Authors:  Floriane C M Braun; Jens van den Brandt; Sören Thomas; Sandra Lange; Juliane Schrank; Claudia Gand; Grzegorz K Przybylski; Katrin Schmoeckel; Barbara M Bröker; Christian A Schmidt; Piotr Grabarczyk
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.